Medical Cannabis - Ghana

Ghana

Ghana is projected to reach a revenue of US$57.53m in the Medical Cannabis market market by 2024.
The market is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 2.64%, leading to a market volume of US$65.55m by 2029.
Among global counterparts, the United States will generate the highest revenue of US$14,530.00m in 2024.
In terms of per person revenues, US$15.59k are generated in 2024 concerning the total population figures.
Ghana's medical cannabis market is steadily growing, attracting international investments and paving the way for future industry regulations and developments.

Key regions: Australia, Europe, South Africa, United States, Netherlands

Market

Region

Region comparison

Currency

Analyst Opinion

The Medical Cannabis market in Ghana has been experiencing significant growth and development in recent years.

Customer preferences: Customers in Ghana are increasingly turning to medical cannabis products for various health and wellness needs. The shift towards natural and alternative remedies has driven demand for medical cannabis products in the country.

Trends in the market: One notable trend in the Ghanaian Medical Cannabis market is the increasing acceptance and legalization of medical cannabis for therapeutic purposes. This trend is in line with global movements towards recognizing the potential benefits of cannabis in treating a range of medical conditions.

Local special circumstances: Ghana's favorable climate and agricultural conditions make it well-suited for cultivating cannabis. The country's rich history of traditional medicine also contributes to the growing acceptance of medical cannabis among the population.

Underlying macroeconomic factors: The growing Medical Cannabis market in Ghana is also influenced by broader macroeconomic factors such as increasing healthcare awareness and the rising prevalence of chronic diseases. As more Ghanaians seek alternative treatment options, the demand for medical cannabis is expected to continue on an upward trajectory.

Methodology

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.